1887

Abstract

(HCV) persists in the majority of infected individuals and is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Chronic hepatitis C is currently treated with interferon (IFN)-α or with a combination of IFN-α and ribavirin. The availability of an HCV replicon system (Lohmann , 285, 110–113, 1999) allowed the investigation of the effects of IFN on genuine HCV replication in cultured cells. It is shown here that IFN-α inhibits subgenomic HCV RNA replication in HuH-7 human hepatoma cells. Immunofluorescence, Western blot and Northern blot analysis revealed that levels of both HCV protein and replicon RNA were reduced after treatment with IFN-α in a dose-dependent manner. In further experiments, it was investigated whether MxA plays a role in the inhibition of HCV. The human MxA protein is an IFN-induced GTPase that has antiviral activity against various RNA viruses. However, HCV RNA replication was not affected in transfected HuH-7 cells that transiently overexpressed MxA. Moreover, a dominant-negative mutant of MxA did not interfere with the antiviral activity of IFN-α against HCV RNA replication. Taken together, these results demonstrate that IFN-α inhibits HCV replicons via an MxA-independent pathway.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-4-723
2001-04-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/4/0820723a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-4-723&mimeType=html&fmt=ahah

References

  1. Aebi, M., Fäh, J., Hurt, N., Samuel, C. E., Thomis, D., Bazzigher, L., Pavlovic, J., Haller, O. & Staeheli, P. ( 1989; ). cDNA structures and regulation of two interferon-induced human Mx proteins. Molecular and Cellular Biology 9, 5062-5072.
    [Google Scholar]
  2. Albanese, M., Bruno-Smiraglia, C., Di Cuonzo, G., Lavagnino, A. & Srihongse, S. ( 1972; ). Isolation of Thogoto virus from Rhipicephalus bursa ticks in western Sicily. Acta Virologica 16, 267.
    [Google Scholar]
  3. Antonelli, G., Simeoni, E., Turriziani, O., Tesoro, R., Redaelli, A., Roffi, L., Antonelli, L., Pistello, M. & Dianzani, F. ( 1999; ). Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-α therapy. Journal of Interferon and Cytokine Research 19, 243-251.[CrossRef]
    [Google Scholar]
  4. Arnheiter, H., Frese, M., Kambadur, R., Meier, E. & Haller, O. ( 1996; ). Mx transgenic mice – animal models of health. Current Topics in Microbiology and Immunology 206, 119-147.
    [Google Scholar]
  5. Ausubel, F. M., Brent, R., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (editors) (1997). Current Protocols in Molecular Biology. New York: John Wiley.
  6. Bartenschlager, R. & Lohmann, V. ( 2000; ). Replication of hepatitis C virus. Journal of General Virology 81, 1631-1648.
    [Google Scholar]
  7. Chomczynski, P. & Sacchi, N. ( 1987; ). Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162, 156-159.
    [Google Scholar]
  8. Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. ( 1989; ). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.[CrossRef]
    [Google Scholar]
  9. Davis, G. L. & Lau, J. Y. ( 1997; ). Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26 (Suppl. 1), 122S–127S.
    [Google Scholar]
  10. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F. & Sato, C. ( 1995; ). Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96, 224-230.[CrossRef]
    [Google Scholar]
  11. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F. & Sato, C. ( 1996; ). Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334, 77-81.[CrossRef]
    [Google Scholar]
  12. Fernández, M., Quiroga, J. A., Martı́n, J., Herrero, M., Pardo, M., Horisberger, M. A. & Carreño, V. ( 1999; ). In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus. Journal of Infectious Diseases 180, 262-267.[CrossRef]
    [Google Scholar]
  13. Foster, G. R. & Thomas, H. C. ( 2000; ). Therapeutic options for HCV – management of the infected individual. Ballière’s Best Practice and Research. Clinical Gastroenterology 14, 255-264.[CrossRef]
    [Google Scholar]
  14. Frese, M., Kochs, G., Meier-Dieter, U., Siebler, J. & Haller, O. ( 1995; ). Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. Journal of Virology 69, 3904-3909.
    [Google Scholar]
  15. Frese, M., Kochs, G., Feldmann, H., Hertkorn, C. & Haller, O. ( 1996; ). Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. Journal of Virology 70, 915-923.
    [Google Scholar]
  16. Haller, O., Frese, M. & Kochs, G. ( 1998; ). Mx proteins: mediators of innate resistance to RNA viruses. Revue Scientifique et Technique Office International des Epizooties 17, 220-230.
    [Google Scholar]
  17. Hefti, H. P., Frese, M., Landis, H., Di Paolo, C., Aguzzi, A., Haller, O. & Pavlovic, J. ( 1999; ). Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections. Journal of Virology 73, 6984-6991.
    [Google Scholar]
  18. Hijikata, M., Ohta, Y. & Mishiro, S. ( 2000; ). Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt −88) correlated with the response of hepatitis C patients to interferon. Intervirology 43, 124-127.[CrossRef]
    [Google Scholar]
  19. Hoofnagle, J. H. ( 1997; ). Hepatitis C: the clinical spectrum of disease. Hepatology 26 (Suppl. 1), 15S–20S.
    [Google Scholar]
  20. Hoofnagle, J. H., Mullen, K. D., Jones, D. B., Rustgi, V., Di Bisceglie, A., Peters, M., Waggoner, J. G., Park, Y. & Jones, E. A. ( 1986; ). Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. New England Journal of Medicine 315, 1575-1578.[CrossRef]
    [Google Scholar]
  21. Jakschies, D., Zachoval, R., Müller, R., Manns, M., Nolte, K. U., Hochkeppel, H. K., Horisberger, M. A., Deicher, H. & von Wussow, P. ( 1994; ). Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology 19, 857-865.
    [Google Scholar]
  22. Jones, L. D. & Nuttall, P. A. ( 1989; ). The effect of virus-immune hosts on Thogoto virus infection of the tick, Rhipicephalus appendiculatus. Virus Research 14, 129-139.[CrossRef]
    [Google Scholar]
  23. Kanerva, M., Melen, K., Vaheri, A. & Julkunen, I. ( 1996; ). Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224, 55-62.[CrossRef]
    [Google Scholar]
  24. Keskinen, P., Nyqvist, M., Sareneva, T., Pirhonen, J., Melén, K. & Julkunen, I. ( 1999; ). Impaired antiviral response in human hepatoma cells. Virology 263, 364-375.[CrossRef]
    [Google Scholar]
  25. Korth, M. J. & Katze, M. G. ( 2000; ). Evading the interferon response: hepatitis C virus and the interferon-induced protein kinase, PKR. Current Topics in Microbiology and Immunology 242, 197-224.
    [Google Scholar]
  26. Laemmli, U. K. ( 1970; ). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.[CrossRef]
    [Google Scholar]
  27. Landis, H., Simon-Jödicke, A., Kloti, A., Di Paolo, C., Schnorr, J. J., Schneider-Schaulies, S., Hefti, H. P. & Pavlovic, J. ( 1998; ). Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. Journal of Virology 72, 1516-1522.
    [Google Scholar]
  28. Leong, J. C., Trobridge, G. D., Kim, C. H. Y., Johnson, M. & Simon, B. ( 1998; ). Interferon-inducible Mx proteins in fish. Immunological Reviews 166, 349-363.[CrossRef]
    [Google Scholar]
  29. Lohmann, V., Körner, F., Koch, J. O., Herian, U., Theilmann, L. & Bartenschlager, R. ( 1999; ). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.[CrossRef]
    [Google Scholar]
  30. Lohmann, V., Körner, F., Dobierzewska, A. & Bartenschlager, R. ( 2001; ). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. Journal of Virology 75, 1437-1449.[CrossRef]
    [Google Scholar]
  31. McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M. H., Cort, S. & Albrecht, J. K. ( 1998; ). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New England Journal of Medicine 339, 1485-1492.[CrossRef]
    [Google Scholar]
  32. MacQuillan, G. C., de Boer, W. B., Platten, M. A., McCaul, K. A., Reed, W. D., Jeffrey, G. P. & Allan, J. E. ( 2000; ). Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatology 15 (Suppl.), J56.
    [Google Scholar]
  33. Marschall, M., Zach, A., Hechtfischer, A., Foerst, G., Meier-Ewert, H. & Haller, O. ( 2000; ). Inhibition of influenza C viruses by human MxA protein. Virus Research 67, 179-188.[CrossRef]
    [Google Scholar]
  34. Moradpour, D. & Blum, H. E. ( 1999; ). Current and evolving therapies for hepatitis C. European Journal of Gastroenterology and Hepatology 11, 1199-1202.[CrossRef]
    [Google Scholar]
  35. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. ( 1982; ). Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Research 42, 3858-3863.
    [Google Scholar]
  36. Pavlovic, J., Zürcher, T., Haller, O. & Staeheli, P. ( 1990; ). Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. Journal of Virology 64, 3370-3375.
    [Google Scholar]
  37. Pavlovic, J., Haller, O. & Staeheli, P. ( 1992; ). Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. Journal of Virology 66, 2564-2569.
    [Google Scholar]
  38. Pavlovic, J., Arzet, H. A., Hefti, H. P., Frese, M., Rost, D., Ernst, B., Kolb, E., Staeheli, P. & Haller, O. ( 1995; ). Enhanced virus resistance of transgenic mice expressing the human MxA protein. Journal of Virology 69, 4506-4510.
    [Google Scholar]
  39. Pietschmann, T., Lohmann, V., Rutter, G., Kurpanek, K. & Bartenschlager, R. ( 2001; ). Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. Journal of Virology 75, 1252-1264.[CrossRef]
    [Google Scholar]
  40. Ponten, A., Sick, C., Weeber, M., Haller, O. & Kochs, G. ( 1997; ). Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. Journal of Virology 71, 2591-2599.
    [Google Scholar]
  41. Reed, K. E. & Rice, C. M. ( 2000; ). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Current Topics in Microbiology and Immunology 242, 55-84.
    [Google Scholar]
  42. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M., Nainan, O., Netesov, S., Nishioka, K., Shin-i, T., Simmonds, P., Smith, D., Stuyver, L. & Weiner, A. ( 1998; ). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Archives of Virology 143, 2493-2503.[CrossRef]
    [Google Scholar]
  43. Schneider-Schaulies, S., Schneider-Schaulies, J., Schuster, A., Bayer, M., Pavlovic, J. & ter Meulen, V. ( 1994; ). Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. Journal of Virology 68, 6910-6917.
    [Google Scholar]
  44. Schnorr, J. J., Schneider-Schaulies, S., Simon-Jödicke, A., Pavlovic, J., Horisberger, M. A. & ter Meulen, V. ( 1993; ). MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. Journal of Virology 67, 4760-4768.
    [Google Scholar]
  45. Staeheli, P. & Haller, O. ( 1985; ). Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Molecular and Cellular Biology 5, 2150-2153.
    [Google Scholar]
  46. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. ( 1998; ). How cells respond to interferons. Annual Review of Biochemistry 67, 227-264.[CrossRef]
    [Google Scholar]
  47. Taylor, D. R. ( 2000; ). Hepatitis C virus: evasion of the interferon-induced antiviral response. Journal of Molecular Medicine 78, 182-190.[CrossRef]
    [Google Scholar]
  48. Theodore, D. & Fried, M. W. ( 2000; ). Natural history and disease manifestations of hepatitis C infection. Current Topics in Microbiology and Immunology 242, 43-54.
    [Google Scholar]
  49. Trepo, C. ( 2000; ). Genotype and viral load as prognostic indicators in the treatment of hepatitis C. Journal of Viral Hepatitis 7, 250-257.[CrossRef]
    [Google Scholar]
  50. Wölk, B., Sansonno, D., Kräusslich, H. G., Dammacco, F., Rice, C. M., Blum, H. E. & Moradpour, D. ( 2000; ). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3–NS4A complex expressed in tetracycline-regulated cell lines. Journal of Virology 74, 2293-2304.[CrossRef]
    [Google Scholar]
  51. World Health Organization ( 1997; ). Hepatitis C: global prevalence. Weekly Epidemiological Record 72, 341–344.
    [Google Scholar]
  52. Zhao, H., De, B. P., Das, T. & Banerjee, A. K. ( 1996; ). Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 220, 330-338.[CrossRef]
    [Google Scholar]
  53. Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. & Silverman, R. H. ( 1999; ). Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258, 435-440.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-4-723
Loading
/content/journal/jgv/10.1099/0022-1317-82-4-723
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error